BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21835526)

  • 21. Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising.
    Hansen RA; Shaheen NJ; Schommer JC
    Clin Ther; 2005 Sep; 27(9):1478-87. PubMed ID: 16291421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of exposure to small pharmaceutical promotional items on treatment preferences.
    Grande D; Frosch DL; Perkins AW; Kahn BE
    Arch Intern Med; 2009 May; 169(9):887-93. PubMed ID: 19433701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When medicine becomes a disease.
    Arabia; 1986 Mar; 5(55):32-6. PubMed ID: 12340711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global marketing of cholesterol-lowering drugs as therapy.
    Elimimian JU; Gilmore JM; Singletary TJ
    J Hosp Mark Public Relations; 2006; 16(1-2):15-28. PubMed ID: 17194684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of pharmaceutical direct advertising: opportunities and obstructions.
    Pinto MB; Pinto JK; Barber JC
    Health Mark Q; 1998; 15(4):89-101. PubMed ID: 10185455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 27. What the DTC movement means to health care.
    Mark Health Serv; 2001; 21(2):24-9. PubMed ID: 11406901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strategic marketing, part 2: the 4 P's of marketing.
    Lexa FJ; Berlin J
    J Am Coll Radiol; 2006 Apr; 3(4):274-7. PubMed ID: 17412059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical company influences on medication prescribing and their potential impact on quality use of medicines.
    Kyle GJ; Nissen LM; Tett SE
    J Clin Pharm Ther; 2008 Oct; 33(5):553-9. PubMed ID: 18834371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What can Johnson & Johnson do to remain a giant in the health care industry?
    Carter T
    J Hosp Mark Public Relations; 2002; 14(1):93-103. PubMed ID: 12569997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Keys to CRM success. How well are contract pharmaceutical companies doing in the CRM game?
    Kros JF; Molis J
    Mark Health Serv; 2004; 24(4):32-6. PubMed ID: 15612224
    [No Abstract]   [Full Text] [Related]  

  • 33. Are pharmaceutical marketing decisions calibrated to communications effects?
    Cavusgil E; Calantone R
    Health Mark Q; 2011 Oct; 28(4):317-36. PubMed ID: 22054028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct-to-consumer advertising affects provider / patient relationship.
    Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Managing the pharmaceutical industry-health system interface.
    Zarowitz BJ; Muma B; Coggan P; Davis G; Barkley GL
    Ann Pharmacother; 2001 Dec; 35(12):1661-8. PubMed ID: 11793639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both sides of pharmaceutical promotion.
    Crigger NJ; Bennison LW
    Adv Nurse Pract; 2007 Jan; 15(1):61-2, 64-5, 74. PubMed ID: 19998677
    [No Abstract]   [Full Text] [Related]  

  • 38. Marketing to the consumer: perspectives from the pharmaceutical industry.
    David C
    Mark Health Serv; 2001; 21(1):5-11. PubMed ID: 11291513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct-to-consumer advertising--education or emotion promotion?
    Wolfe SM
    N Engl J Med; 2002 Feb; 346(7):524-6. PubMed ID: 11844857
    [No Abstract]   [Full Text] [Related]  

  • 40. Examining the applicability of market forecasting models to new pharmaceutical products.
    Agrawal M; Calantone RJ
    Health Mark Q; 1996; 13(4):17-31. PubMed ID: 10159642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.